Myeloproliferative Disorders

Essential Thrombocytosis/Thrombocythemia (High Platelet Count)

• Thrombocytosis and Thrombosis (2007)
• Management of Polycythemia Vera and Essential Thrombocythemia (2005)

Myelofibrosis

• Biology and Treatment of Primary Myelofibrosis (2007)
• Chronic Myelogenous Leukemia and Myeloproliferative Disease (2004)

Other

• Myeloproliferative Disease in Pregnancy and Other Management Issues (2006)
• Recent Advances in the Diagnosis and Treatment of Hypereosinophilic Syndromes (2005)
• Platelets and Thrombosis in Myeloproliferative Diseases (2005)

Pathophysiology / Diagnositics

• Navigating the Evolving Paradigms in the Diagnosis and Treatment of Myeloproliferative Disorders (2007)
• The Genetic Basis of Myeloproliferative Disorders (2007)
• Role of JAK-STAT Signaling in the Pathogenesis of Myeloproliferative Disorders (2006)
• Classification, Diagnosis and Management of Myeloproliferative Disorders in the JAK2V617F Era (2006)
• On the Molecular Origins of the Chronic Myeloproliferative Disorders: It All Makes Sense (2005)

Polycythemia (High Red Blood Cell Count)

• A Unique Activating Mutation in JAK2 (V617F) Is at the Origin of Polycythemia Vera and Allows a New Classification of Myeloproliferative Diseases (2005)
• Management of Polycythemia Vera and Essential Thrombocythemia (2005)